Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, Unilateral Breast Neoplasms, bilateral breast carcinoma, breast disorder, breast neoplasm, inflammatory breast carcinoma, neoplasm, skin disorder, triple-negative breast carcinomaActive, not recruitingPhase 22026-06-30NCT03012100

2 results · Page 1 of 1

Swipe the table sideways for more columns.

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Carle Cancer Center NCI Community Oncology Research ProgramUrbanaUnited States4
City of Hope Comprehensive Cancer CenterDuarteUnited States263
Dana-Farber Cancer InstituteBostonUnited States626
INOVA Fairfax HospitalFalls ChurchUnited States126
Marshfield Medical Center-MarshfieldMarshfieldUnited States279
Massachusetts General Hospital Cancer CenterBostonUnited States178
Mayo Clinic in ArizonaScottsdaleUnited States191
Mayo Clinic in FloridaJacksonvilleUnited States224
Mayo Clinic in RochesterRochesterUnited States687
Ochsner Medical Center JeffersonNew OrleansUnited States192
University of Chicago Comprehensive Cancer CenterChicagoUnited States273
University of Miami Miller School of Medicine-Sylvester Cancer CenterMiamiUnited States232